Rosenberg, Paul B.

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18 F-AV-45 (Flobetapir F 18)

Wong, D. F., Rosenberg, P. B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H. T., Dannals, R. F., Nandi, A., Brašić, J. R., Ye, W., et al. (2010) · Journal of Nuclear Medicine

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 684

Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial

Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., et al. (2014) · JAMA

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 572

The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations

Ismail, Z., for the NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART), Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., et al. (2017) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

Cited by 530

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

Lanctôt, K. L., Amatniek, J., Ancoli‐Israel, S., Arnold, S. E., Ballard, C., Cohen‐Mansfield, J., Ismail, Z., Lyketsos, C., Miller, D. S., Musiek, E., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 395

Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

Geda, Y. E., Schneider, L. S., Gitlin, L. N., Miller, D. S., Smith, G. S., Bell, J., Evans, J., Lee, M., Porsteinsson, A., Lanctôt, K. L., et al. (2013) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 378

The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease

Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Geda, Y. E., & Lyketsos, C. G. (2013) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

Cited by 366

Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?

Rosenberg, P. B., Nowrangi, M. A., & Lyketsos, C. G. (2015) · Molecular Aspects of Medicine

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 302

Sertraline for the treatment of depression in Alzheimer disease

Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., et al. (2010) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 250

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer’s Disease: A Randomized, Placebo-Controlled Trial

Rosenberg, P. B., Lanctôt, K. L., Drye, L. T., Herrmann, N., Scherer, R. W., Bachman, D. L., Mintzer, J. E., & ADMET investigators (2013) · The Journal of Clinical Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 191

Predisposing Factors for Postoperative Delirium After Hip Fracture Repair in Individuals with and without Dementia

Lee, H. B., Mears, S. C., Rosenberg, P. B., Leoutsakos, J. S., Gottschalk, A., & Sieber, F. E. (2011) · Journal of the American Geriatrics Society

Intensive Care Unit Cognitive DisordersHip and Femur Fractures

Cited by 175

Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study

Peters, M. E., Rosenberg, P. B., Steinberg, M., Norton, M. C., Welsh-Bohmer, K. A., Hayden, K. M., Breitner, J., Tschanz, J. T., & Lyketsos, C. G. (2013) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studies

Cited by 167

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

Rosenberg, P. B., Mielke, M. M., Han, D., Leoutsakos, J. S., Lyketsos, C. G., Rabins, P. V., Zandi, P. P., Breitner, J. C. S., Norton, M. C., Welsh‐Bohmer, K. A., et al. (2012) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 127

Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation

Leoutsakos, J.-M. S., Yan, H., Anderson, W. S., Asaad, W. F., Baltuch, G., Burke, A., Chakravarty, M. M., Drake, K. E., Foote, K. D., Fosdick, L., et al. (2018) · Journal of Alzheimer s Disease

Deep Brain Stimulation and Movement DisordersTranscranial Magnetic Stimulation Studies

Cited by 104

Agitation in cognitive disorders: progress in the International Psychogeriatric Association consensus clinical and research definition.

Sano, M., Cummings, J., Auer, S., Bergh, S., Fischer, C. E., Gerritsen, D., Grossberg, G., Ismail, Z., Lanctôt, K., Lapid, M. I., et al. (2024) · International Psychogeriatrics

Dementia and Cognitive Impairment ResearchIntensive Care Unit Cognitive Disorders

Cited by 91

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease

Nowrangi, M. A., & Rosenberg, P. B. (2015) · Frontiers in Aging Neuroscience

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 87

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial

Drye, L. T., Spragg, D., Devanand, D. P., Frangakis, C., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., Pelton, G., Pollock, B. G., et al. (2014) · PLoS ONE

Cardiac electrophysiology and arrhythmiasPharmacovigilance and Adverse Drug Reactions

Cited by 59

Citalopram for agitation in Alzheimer's disease: Design and methods

Drye, L. T., Ismail, Z., Porsteinsson, A. P., Rosenberg, P. B., Weintraub, D., Marano, C., Pelton, G., Frangakis, C., Rabins, P. V., Munro, C. A., et al. (2012) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 52

Cognitive Outcomes After Sertaline Treatment in Patients With Depression of Alzheimer Disease

Munro, C. A., Longmire, C. F., Drye, L. T., Martin, B. K., Frangakis, C. E., Meinert, C. L., Mintzer, J. E., Porsteinsson, A. P., Rabins, P. V., Rosenberg, P. B., et al. (2012) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 49

Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

Rosenberg, P. B., Drye, L. T., Porsteinsson, A. P., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., et al. (2015) · International Psychogeriatrics

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 28